XT
TOVX icon

XTX Topco’s Theriva Biologics TOVX Stock Holding History

XTX Topco’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5K Sell
53,868
-40,752
-43% -$12.1K ﹤0.01% 3982
2026
Q1 		$18.5K Buy
94,620
+55,175
+140% +$10.9K ﹤0.01% 3568
2025
Q4 		$8.3K Buy
39,445
+6,546
+20% +$1.94K ﹤0.01% 3207
2025
Q3 		$13.3K Buy
32,899
+15,712
+91% +$6.8K ﹤0.01% 2400
2025
Q2 		$7.46K Buy
+17,187
New +$13.9K ﹤0.01% 2246

Other funds holding TOVX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

XTX Topco's TOVX Position: Q2 2026 in Review

XTX Topco reduced its Theriva Biologics (TOVX) stake by 43% in Q2 2026, selling an estimated $12.1K and leaving 53,868 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3982.

XTX Topco first reported a position in TOVX in Q2 2025 and has held it in 5 quarters since. The position peaked at $18.5K in Q1 2026. 26 funds tracked by Wall St. Rank hold TOVX as of Q2 2026.

  • XTX Topco held 53,868 shares of Theriva Biologics worth $13.5K as of Q2 2026.
  • XTX Topco sold 40,752 Theriva Biologics shares in Q2 2026, an estimated $12.1K.
  • Theriva Biologics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3982 holding.
  • XTX Topco first reported a position in Theriva Biologics in Q2 2025 and has held it in 5 quarters since.
  • XTX Topco's Theriva Biologics position peaked at $18.5K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held Theriva Biologics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.